Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
NeoChord, Inc.
3197
NeoChord, Inc.
Technology
Biotechnology
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation.
Suggest edits
Type
B2c
Founded
2007
Raised
$55M
Follow us
Companies in the same industry
Ubiquigent
Fidelity Biosciences
Biotherapeutics
ZIOPHARM Oncology
Saphetor
Biogen
Rex Animal Health
Aperiomics
StemCellsInc
QLT
Alexa global traffic share
Overview
Funding
3
People
Add info
Latest funding
Show all
$32,000,000
Venture capital (Series D) - 2019
Strategic Healthcare Investment Partners
$20,000,000
Venture capital (Series C) - 2015
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$32,000,000
Venture capital (Series D)
FinSMEs
NeoChord Raises Additional $7M in Series D Financing
